English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Thesis

Unified Total Synthesis of the Antibiotic Macrolides Aldgamycin N and Mycinamicin IV & De novo Syntheses of their Carbohydrate Units

MPS-Authors
/persons/resource/persons256644

Späth,  Georg
Research Department Fürstner, Max-Planck-Institut für Kohlenforschung, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Späth, G. (2022). Unified Total Synthesis of the Antibiotic Macrolides Aldgamycin N and Mycinamicin IV & De novo Syntheses of their Carbohydrate Units. PhD Thesis, Technische Universität, Dortmund.


Cite as: https://hdl.handle.net/21.11116/0000-000A-CEB5-2
Abstract
The present thesis provides a unified total synthesis approach to the 16-membered macrolide antibiotics
aldgamycin N and mycinamicin IV. Both natural products represent two distinct series of macrolide targets,
which are characterized by a highly conserved “eastern” acid half but subtle variations within their
macrocyclic frameworks, as well as their specific glycosides. The unified total syntheses are enabled by the
swift assembly of the macrocyclic frameworks by merging individual carbonyl and alkyne modules as the
two main synthetic fragments and the subsequent ruthenium-catalyzed transformation of the C–C triple
bonds into the key functionalities distinguishing the individual targets. The eastern carbonyl fragments are
reached from a single common terminal alkene building block formed on multi-gram scale by an asymmetric
vinylogous Mukaiyama-type aldol reaction. Wacker oxidation of the common alkene terminus provides a
ketone as the anchor point towards aldgamycin N, while an unprecedented stereo- and branch-selective
hydroformylation at this site controlled by a literature-reported rhodium complex furnishes an aldehyde to
serve as the handle for the preparation of mycinamicin IV. After combination of these fragments with their
respective alkyne counterparts by carbonyl addition and closure of the macrolactone rings by an unusual
stannoxane-mediated transesterification, the individual target moieties are forged using ruthenium-
catalyzed transformations of the propargylic alcohols obtained from the carbonyl additions. Specifically,
these late-stage key steps comprise a regioselective hydrostannation/Chan-Lam-type oxygenative coupling
sequence to unveil the acyloin of aldgamycin N, and a rare example of a rearrangement of a secondary
propargylic alcohol into the unsaturated ketone of mycinamicin IV. Completion of the target syntheses by
attachment of the carbohydrates proved challenging and required close attention to both the timing of the
glycosidation events and the exact glycosylation conditions employed. Systematic screening of the
glycosylation conditions showcases the crucial distinction in reactivity between different silyl triflates for
the activation of trichloroacetimidate donors. The rare branched-chain octose D-aldgarose and the basic
amino sugar D-desosamine, required as the 4,6-dideoxy carbohydrates at the C5 position of both natural
products, are also reached by a unified approach. The employed common building block is synthesized
using an enantioselective hetero-Diels-Alder reaction, and intermediates of both de novo syntheses may
serve the practical preparation of other naturally occurring 4,6-dideoxy sugars as well as derivatives thereof.